The 2nd COVID-19 Booster successfully decreases nursing home hospitalizations and fatalities. It is, however, less effective in avoiding serious infections. A variety of reasons contribute to poor immunization rates in nursing homes. The primary motivators include vaccination apprehension, lack...

Acute respiratory distress syndrome (ARDS) is a severe COVID-19 side effect. It is associated with a high mortality rate, particularly in older individuals and those with pulmonary and other comorbidities. We examined whether ruxolitinib therapy could improve the outcome of COVID-19 ARDS patients...

A variety of variables, including changes in environmental and socio-economic conditions, contribute to the formation of novel infectious illnesses. Climate change, globalization, and migration from rural to urban regions are examples of these shifts. Infections from the animal kingdom are most...